Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013 (2013), Article ID 539658, 9 pages
http://dx.doi.org/10.1155/2013/539658
Research Article

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy

1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
2Department of Ophthalmology, King Abdulaziz University Hospital, Old Airport Road, P.O. Box 245, Riyadh 11411, Saudi Arabia
3Laboratory of Histochemistry and Cytochemistry, University of Leuven, Belgium

Received 22 December 2012; Accepted 12 February 2013

Academic Editor: Ghulam Mohammad

Copyright © 2013 Ahmed M. Abu El-Asrar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Dome, J. Dobos, J. Tovari et al., “Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease,” Cytometry A, vol. 73, no. 3, pp. 186–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Abu El-Asrar, S. Struyf, H. Verbeke, J. Van Damme, and K. Geboes, “Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes,” Acta Ophthalmologica, vol. 89, no. 3, pp. 222–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Abu El-Asrar, S. Struyf, G. Opdenakker, J. van Damme, and K. Geboes, “Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes,” Molecular Vision, vol. 16, pp. 1098–1107, 2010. View at Google Scholar · View at Scopus
  5. C. Kalka, H. Masuda, T. Takahashi et al., “Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects,” Circulation Research, vol. 86, no. 12, pp. 1198–1202, 2000. View at Google Scholar · View at Scopus
  6. B. Li, E. E. Sharpe, A. B. Maupin et al., “VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization,” FASEB Journal, vol. 20, no. 9, pp. E664–E676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Shibuya, “Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis,” Journal of Biochemistry and Molecular Biology, vol. 39, no. 5, pp. 469–478, 2006. View at Google Scholar · View at Scopus
  8. J. M. L. Ebos, G. Bocci, S. Man et al., “A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma,” Molecular Cancer Research, vol. 2, no. 6, pp. 315–326, 2004. View at Google Scholar · View at Scopus
  9. J. M. L. Ebos, C. R. Lee, E. Bogdanovic et al., “Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth,” Cancer Research, vol. 68, no. 2, pp. 521–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Fazel, L. Chen, D. Angoulvant et al., “Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury,” FASEB Journal, vol. 22, no. 3, pp. 930–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. H. Huang, Y. H. Chen, C. H. Wang et al., “Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor Cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 8, pp. 1179–1184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Heissig, Z. Werb, S. Rafii, and K. Hattori, “Role of c-kit/Kit ligand signaling in regulating vasculogenesis,” Thrombosis and Haemostasis, vol. 90, no. 4, pp. 570–576, 2003. View at Google Scholar · View at Scopus
  13. T. S. Li, K. Hamano, M. Nishida et al., “CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation,” American Journal of Physiology, vol. 285, no. 3, pp. H931–H937, 2003. View at Google Scholar · View at Scopus
  14. Y. Miyamoto, T. Suyama, T. Yashita, H. Akimaru, and H. Kurata, “Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells,” Journal of Molecular and Cellular Cardiology, vol. 43, no. 5, pp. 627–635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Dentelli, A. Rosso, A. Balsamo et al., “C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium,” Blood, vol. 109, no. 10, pp. 4264–4271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Matsui, T. Wakabayashi, M. Asada, K. Yoshimatsu, and M. Okada, “Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells,” Journal of Biological Chemistry, vol. 279, no. 18, pp. 18600–18607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Sun, A. M. Hui, Q. Su et al., “Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain,” Cancer Cell, vol. 9, no. 4, pp. 287–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Kelly, Y. Zhang, R. M. Gow, S. Itescu, and R. E. Gilbert, “Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes,” Diabetes and Vascular Disease Research, vol. 2, no. 2, pp. 76–80, 2005. View at Google Scholar · View at Scopus
  19. A. M. Turner, L. G. Bennett, N. L. Lin et al., “Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines,” Blood, vol. 85, no. 8, pp. 2052–2058, 1995. View at Google Scholar · View at Scopus
  20. A. Kaminski, N. Ma, P. Donndorf et al., “Endothelial NOS is required for SDF-1α/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells,” Laboratory Investigation, vol. 88, no. 1, pp. 58–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Zheng, G. Fu, T. Dai, and H. Huang, “Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1α/CXCR4 via PI3K/Akt/eNOS signal transduction pathway,” Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 274–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Aicher, C. Heeschen, C. Mildner-Rihm et al., “Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells,” Nature Medicine, vol. 9, no. 11, pp. 1370–1376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-I. Hiasa, M. Ishibashi, K. Ohtani et al., “Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization,” Circulation, vol. 109, no. 20, pp. 2454–2461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Herrler, S. F. Leicht, S. Huber et al., “Prostaglandin e positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy,” Journal of Vascular Research, vol. 46, no. 4, pp. 333–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Tamura, T. Sakurai, and H. Kogo, “Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells,” Vascular Pharmacology, vol. 44, no. 6, pp. 411–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Jantus-Lewintre, E. Sanmartīn, R. Sirera et al., “Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC,” Lung Cancer, vol. 74, no. 2, pp. 326–331, 2011. View at Publisher · View at Google Scholar
  28. S. Swendeman, K. Mendelson, G. Weskamp et al., “VEGF-a stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between vegfr2 and ERK signaling,” Circulation Research, vol. 103, no. 9, pp. 916–918, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Stachon, A. Aweimer, T. Stachon et al., “Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia,” Growth Factors, vol. 27, no. 2, pp. 71–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Abu El-Asrar, L. Missotten, and K. Geboes, “Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes,” British Journal of Ophthalmology, vol. 92, no. 11, pp. 1534–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Litz and G. W. Krystal, “Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells,” Molecular Cancer Therapeutics, vol. 5, no. 6, pp. 1415–1422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Pedersen, T. Löfstedt, J. Sun, L. Holmquist-Mengelbier, S. Påhlman, and L. Rönnstrand, “Stem cell factor induces HIF-1α at normoxia in hematopoietic cells,” Biochemical and Biophysical Research Communications, vol. 377, no. 1, pp. 98–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Z.-B. Han, H. Ren, H. Zhao et al., “Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF),” Carcinogenesis, vol. 29, no. 10, pp. 1853–1861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. A. Abd El-Asrar, L. Missotten, and K. Geboes, “Expression of hypoxia-inducible factor-1α and the protein products of its target genes in diabetic fibrovascular epiretinal membranes,” British Journal of Ophthalmology, vol. 91, no. 6, pp. 822–826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. G. D. Demetri, “Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors,” Seminars in Oncology, vol. 38, supplement 1, pp. S10–S19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Takeshima and J. I. Kuratsu, “A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma,” Surgical Neurology, vol. 60, no. 4, pp. 321–324, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. E. DePrimo, X. Huang, M. E. Blackstein et al., “Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure,” Clinical Cancer Research, vol. 15, no. 18, pp. 5869–5877, 2009. View at Google Scholar · View at Scopus
  38. M. Kawakita, Y. Yonemura, H. Miyake et al., “Soluble c-kit molecule in serum from healthy individuals and patients with haemopoietic disorders,” British Journal of Haematology, vol. 91, no. 1, pp. 23–29, 1995. View at Google Scholar · View at Scopus
  39. C. Akin, L. B. Schwartz, T. Kitoh et al., “Soluble stem cell factor receptor (CD 117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology,” Blood, vol. 96, no. 4, pp. 1267–1273, 2000. View at Google Scholar · View at Scopus
  40. Y. Nakamura, F. Tajima, K. Ishiga et al., “Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice,” Experimental Hematology, vol. 32, no. 4, pp. 390–396, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Ishiga, “Serum-soluble c-kit levels during mobilization of peripheral blood stem cells correlate with stem cell yield,” International Journal of Hematology, vol. 72, no. 2, pp. 186–193, 2000. View at Google Scholar · View at Scopus
  42. H. Joensuu, M. Puputti, H. Sihto, O. Tynninen, and N. N. Nupponen, “Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme,” Journal of Pathology, vol. 207, no. 2, pp. 224–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Turner, L. G. Bennett, N. L. Lin et al., “Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines,” Blood, vol. 85, no. 8, pp. 2052–2058, 1995. View at Google Scholar · View at Scopus
  44. L. Ying and L. J. Hofseth, “An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer,” Cancer Research, vol. 67, no. 4, pp. 1407–1410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. R. D. Minshall, W. C. Sessa, R. V. Stan, R. G. W. Anderson, and A. B. Malik, “Caveolin regulation of endothelial function,” American Journal of Physiology, vol. 285, no. 6, pp. L1179–L1183, 2003. View at Google Scholar · View at Scopus
  46. S. Douros, B. A. Phillips, A. Nadel, and S. A. Obstbaum, “Human vitreal prostaglandin levels and proliferative diabetic retinopathy,” Documenta Ophthalmologica, vol. 103, no. 1, pp. 27–34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. F. J. Descamps, E. Martens, D. Kangave et al., “The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage,” Experimental Eye Research, vol. 83, no. 2, pp. 401–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. M. Abu El-Asrar, S. Struyf, D. Kangave, K. Geboes, and J. Van Damme, “Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy,” European Cytokine Network, vol. 17, no. 3, pp. 155–165, 2006. View at Google Scholar · View at Scopus